Polish Government Plans Ban on Flavoured Nicotine Pouches and Disposable E-Cigarettes

Dec.05.2025
Polish Government Plans Ban on Flavoured Nicotine Pouches and Disposable E-Cigarettes
Poland’s government is preparing to amend the Act on Protection of Health from the Consequences of Tobacco Use to ban the sale of flavoured nicotine pouches and disposable e-cigarettes. The Health Ministry says the goal is to protect youth from nicotine addiction, citing World Health Organization data on the risks of such products. However, industry representatives and legal experts argue the proposal is abrupt and could expand the illicit market.

Key points

 

  • Poland’s Cabinet is set to discuss a new bill restricting nicotine product sales.
  • The proposal bans flavoured nicotine pouches and disposable e-cigarettes to protect youth.
  • The Health Ministry cites WHO data showing increased e-cigarette use among minors.
  • Business groups warn of policy instability and potential black-market expansion.
  • Legal experts urge education and enforcement rather than new prohibitions.

 


 

2Firsts, December 5, 2025 – According to Rzeczpospolita, the Polish government is preparing to amend the Act on Protection of Health from the Consequences of Tobacco Use to prohibit the sale of flavoured nicotine pouches and disposable e-cigarettes. The draft will be debated at Thursday’s Standing Committee of the Council of Ministers meeting.

 

The Health Ministry, which authored the bill, argues the changes aim to protect young people from nicotine addiction. The ministry cites World Health Organization (WHO) reports highlighting the health risks of nicotine pouches and the increasing popularity of e-cigarettes among adolescents. Data from the 2022 Global Youth Tobacco Survey show that 22.3% of Polish children aged 12–15 use e-cigarettes (21.2% of boys and 23.4% of girls).

 

However, the proposal sparked backlash during public consultations. Numerous organizations—including medical associations—said the plan misrepresents concern for public health and could surprise the tobacco sector. Many warned of a black-market surge, typical of overly restrictive policies.

 

Jakub Bińkowski, board member of the Union of Entrepreneurs and Employers (ZPP), said:

 

“Every business expects stability and predictability from the state. Unfortunately, the tobacco sector has not enjoyed that in recent years, with unexpected tax hikes and sudden bans. A ban will likely expand the shadow market, introducing products of unknown origin and potentially higher toxicity.”

 

Legal expert Dr. Anna Partyka-Opiela of the Rymarz Zdort Maruta law firm added that the ban may not meet constitutional standards of usefulness, necessity, and proportionality, and might fail to achieve its intended health goals.

 

Experts further note that nicotine pouches are primarily used by former smokers trying to quit. They argue that better enforcement of existing age-restriction laws and education campaigns would yield healthier outcomes.

 

Critics also pointed out that Poland has already imposed an excise tax on nicotine pouches since July 1, 2025, and the May 2025 amendment to the anti-tobacco law set strict limits: a ban on sales to minors, a ban on online sales, and a nicotine cap of 20 mg/g.

 

Image source: Rzeczpospolita

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Tobacco International (HK) Announces FY2025 Results: Revenue Reaches HK$14.58 Billion, Up 11.5% Year-on-Year
China Tobacco International (HK) Announces FY2025 Results: Revenue Reaches HK$14.58 Billion, Up 11.5% Year-on-Year
China Tobacco International (HK) Company Limited announced its audited results for the year ended December 31, 2025. Revenue was HK$14.58 billion, profit before taxation was HK$1.28 billion, and profit attributable to owners of the Company was HK$0.98 billion, with basic and diluted EPS of HK$1.42. The Board proposed a final dividend of HK$0.33 per share; together with an interim dividend of HK$0.19 per share, the full-year dividend totaled HK$0.52 per share.
Mar.06 by 2FIRSTS.ai
FDA and IKE Tech Hold Formal Listening Session on Youth Access and Illicit ENDS Products
FDA and IKE Tech Hold Formal Listening Session on Youth Access and Illicit ENDS Products
U.S. Food and Drug Administration’s Center for Tobacco Products held a formal listening session with IKE Tech LLC to discuss youth prevention at the point of use for ENDS products, the circulation of illicit products in the supply chain, and the regulatory treatment of software in tobacco products.
Apr.10 by 2FIRSTS.ai
Pennsylvania Lawmaker Seeks to Keep Vape Shops Away From Schools
Pennsylvania Lawmaker Seeks to Keep Vape Shops Away From Schools
A Pennsylvania lawmaker is seeking legislation that would require newly licensed vape shops to be located at least 1,000 feet away from K-12 schools in the state. The proposal was put forward by State Representative Chris Pielli.
Mar.11 by 2FIRSTS.ai
BAT Malaysia Launches Workforce Exercise to Improve Efficiency and Align With Future Business Direction
BAT Malaysia Launches Workforce Exercise to Improve Efficiency and Align With Future Business Direction
British American Tobacco Malaysia has announced a workforce optimisation exercise aimed at streamlining operations ahead of a major shift in its distribution strategy.
Apr.01 by 2FIRSTS.ai
Nicokick and zone Extend NASCAR Collaboration for April 19 Kansas City Race
Nicokick and zone Extend NASCAR Collaboration for April 19 Kansas City Race
Nicokick.com said it will continue its collaboration with zone for a second year at the April 19 NASCAR race in Kansas City, appearing on Richard Childress Racing’s No. 8 Chevrolet driven by Kyle Busch. The 2026 race-weekend campaign for verified adult nicotine consumers aged 21 and older includes the exclusive launch of zone Cranberry and a limited-edition five-flavor mix pack selected by Busch.
Apr.16 by 2FIRSTS.ai
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
A Fifth Circuit panel upheld the U.S. Food and Drug Administration’s 2021 final rule requiring companies seeking premarket authorization for new tobacco products to include information on health-risk investigations. In a published opinion, the court found FDA satisfied the Regulatory Flexibility Act’s procedural requirements and reasonably relied on the economic analysis from the 2016 “deeming rule” as a factual basis to certify limited impact on small businesses.
Feb.27 by 2FIRSTS.ai